At the time of writing, Lipocine Inc [LPCN] stock is trading at $11.13, down -1.15%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LPCN shares have gain 38.95% over the last week, with a monthly amount glided 253.33%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lipocine Inc [NASDAQ: LPCN] stock has seen the most recent analyst activity on June 24, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $3. Previously, Ladenburg Thalmann upgraded its rating to Buy on December 10, 2020, and kept the price target unchanged to $3. On January 12, 2018, H.C. Wainwright reiterated its Buy rating and revised its price target to $3 on the stock. Canaccord Genuity downgraded its rating to a Hold and decreased its price target to $2 on January 11, 2018. H.C. Wainwright started tracking with a Buy rating for this stock on October 07, 2016, and assigned it a price target of $25. In a note dated July 22, 2015, ROTH Capital initiated an Buy rating and provided a target price of $36 on this stock.
For the past year, the stock price of Lipocine Inc fluctuated between $2.52 and $12.37. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Lipocine Inc [NASDAQ: LPCN] shares were valued at $11.13 at the most recent close of the market. An investor can expect a potential drop of -10.15% based on the average LPCN price forecast.
Analyzing the LPCN fundamentals
Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -1.46%, Pretax Profit Margin comes in at -1.27%, and Net Profit Margin reading is -1.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.31 and Total Capital is -0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Lipocine Inc [NASDAQ:LPCN] has a current ratio of 8.25. Also, the Quick Ratio is 8.25, while the Cash Ratio stands at 2.02. Considering the valuation of this stock, the price to sales ratio is 14.30, the price to book ratio is 4.27.
